MXEBX
Price
$16.96
Change
-$0.15 (-0.88%)
Updated
Sep 5 closing price
Net Assets
690.1M
VTSAX
Price
$155.55
Change
-$0.31 (-0.20%)
Updated
Sep 5 closing price
Net Assets
1.95T
Interact to see
Advertisement

MXEBX vs VTSAX

Header iconMXEBX vs VTSAX Comparison
Open Charts MXEBX vs VTSAXBanner chart's image
Empower Core Strategies US Eq Instl
Price$16.96
Change-$0.15 (-0.88%)
VolumeN/A
Net Assets690.1M
Vanguard Total Stock Mkt Idx Adm
Price$155.55
Change-$0.31 (-0.20%)
VolumeN/A
Net Assets1.95T
MXEBX vs VTSAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MXEBX vs. VTSAX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MXEBX is a Buy and VTSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.95T vs. MXEBX (690M). MXEBX pays higher dividends than VTSAX: MXEBX (1.52) vs VTSAX (1.16). MXEBX was incepted earlier than VTSAX: MXEBX (7 years) vs VTSAX (25 years). MXEBX (0.71) is less costly to investors than VTSAX (0.04). MXEBX is a more actively managed with annual turnover of: 20.00 vs. VTSAX (2.00). MXEBX has a lower initial minimum investment than VTSAX: MXEBX (0) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 18.04 vs. MXEBX (8.56). VTSAX return over 5 years is better than : 84.96 vs. MXEBX (60.19).
MXEBXVTSAXMXEBX / VTSAX
Total Expense Ratio0.550.041,375%
Annual Report Gross Expense Ratio0.710.041,775%
Fund Existence7 years25 years-
Gain YTD9.64910.34693%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets690M1.95T0%
Annual Yield % from dividends1.521.16131%
Returns for 1 year8.5618.0447%
Returns for 3 years53.8563.6685%
Returns for 5 years60.1984.9671%
Returns for 10 yearsN/A224.91-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBIO53.381.55
+2.99%
BridgeBio Pharma
INBX28.180.46
+1.66%
Inhibrx Biosciences Inc.
MAN41.26-0.05
-0.12%
ManpowerGroup
CNVS3.71-0.07
-1.85%
Cineverse Corp
UPC3.55-0.18
-4.83%
Universe Pharmaceuticals Inc